Think Before You Ink: Tattoo Safety

Image Español Tattoos are more popular than ever. About 30% of all Americans, and 40% of those aged 18-34 years old, have at least one tattoo, according to polling by the firm Ipsos. While state and local authorities oversee the practice of tattooing, inks and pigments used in tattoos are subject to U.S. Food and…

How Sweet It Is: All About Sweeteners

Image Español Whether it’s to cut down on the number of calories they consume or any of a variety of other reasons, some people choose sweeteners other than sugar. Sweeteners such as aspartame, sucralose, and stevia-derived substances, for example, are widely used ingredients in foods and beverages marketed as “sugar-free” or “diet.” Some of the products…

Oxygenator Devices Used for Extracorporeal Circulation – Letter to Health Care Providers

June 9, 2023 The U.S. Food and Drug Administration (FDA) is providing information to health care providers and facilities on the use of oxygenators in extracorporeal circulation.   On May 18, 2023, Getinge/Maquet issued an Urgent Medical Device Removal notice to inform users to not use all Quadrox Oxygenators and certain Getinge/Maquet Venous Hardshell Cardiotomy…

Qué tan dulce es: todo sobre los edulcorantes

Image English Ya sea para reducir la cantidad de calorías que consumen o por cualquier otro motivo, algunas personas eligen edulcorantes diferentes del azúcar. Los edulcorantes como el aspartamo, la sucralosa y las sustancias derivadas de la estevia, por ejemplo, son ingredientes muy utilizados en alimentos y bebidas comercializados como “sin azúcar” o “dietéticos”. Algunos…

FDA D.I.S.C.O. Burst Edition: FDA approval of Polivy (polatuzumab vedotin-piiq) for previously untreated diffuse large B-cell lymphoma, not otherwise specified, and high-grade B-cell lymphoma

Podcast Welcome back to the D.I.S.C.O., FDA’s Drug Information Soundcast in Clinical Oncology, Burst Edition, brought to you by FDA’s Division of Drug Information in partnership with FDA’s Oncology Center of Excellence. Today we’ll provide a quick update on a recent FDA cancer drug approval. On April 19, 2023, the FDA approved polatuzumab vedotin-piiq, brand…

Don’t Use Products Marketed to Treat Molluscum, a Common Skin Condition

Image Español If you’re bothered by bumps on your skin, don’t try to diagnose yourself or treat your condition with products that haven’t been approved by the U.S. Food and Drug Administration. Instead, visit a health care professional for a proper diagnosis and to make a treatment plan. One common condition that some people try…

ACTUALIZACIÓN: Uso del dispositivo Renuvion/J-Plasma para determinados procedimientos estéticos: Comunicación de seguridad de la FDA

English Fecha de publicación: 10 de mayo de 2023 La Administración de Alimentos y Medicamentos de los EE. UU. (FDA, por sus siglas en inglés) está proporcionando otra actualización sobre el sistema de dispositivos Renuvion/J-Plasma de Apyx Medical con respecto al uso del dispositivo para ciertos procedimientos estéticos de la piel y una autorización adicional…